by TractManager | Dec 29, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on intradialytic parenteral nutrition (IDPN) for nutritional support in adults with end-stage renal disease (ESRD) who are undergoing hemodialysis.Technology Description: IDPN is an intravenous infusion of essential nutrients...
by TractManager | Dec 23, 2020 | Emerging Technology Report
Inolimomab (proposed name, Leukotac) is an immunotherapy monoclonal antibody targeting the interleukin-2 receptor (IL-2) in development for the treatment of acute graft versus host disease (aGVHD). If you have a Hayes login, click here to view the full report on the...
by TractManager | Dec 22, 2020 | Health Technology Assessment
Focus of the Report: The use of radiofrequency ablation (RFA) of the genicular nerves for the treatment of osteoarthritis of the knee (KOA).Technology Description: In this report, RFA is defined as ablation of the peripheral nerves of the knee to relieve the pain...
by TractManager | Dec 22, 2020 | Emerging Technology Report
Inclisiran is a subcutaneously administered, investigational RNAi therapeutic that decreases hepatic synthesis of proprotein convertase subtilisin kexin type 9 (PCSK9), leading to increased low-density lipoprotein (LDL) receptor expression on the hepatocyte cell...
by TractManager | Dec 21, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on the efficacy and safety of the 5-hydroxytryptamine 1F (5-HT1F) receptor agonist lasmiditan (Reyvow) for acute treatment of migraines.Technology Description: The 5-HT1F receptors are found on secondary trigeminal neurons, the...
Recent Comments